UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Pathways and therapeutic targets in melanoma

Oncotarget, 2014-04, Vol.5 (7), p.1701-1752

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathways and therapeutic targets in lung cancer

Oncotarget, 2014-03, Vol.5 (6), p.1392-1433

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathways and targets in prostate cancer

Oncotarget, 2014-09, Vol.5 (17), p.7217-7259

2014

Link zum Volltext

Verfügbarkeit prüfen

CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation

Cell cycle (Georgetown, Tex.), 2010-12, Vol.9 (24), p.4941-4953

2010

Link zum Volltext

Verfügbarkeit prüfen

A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle

Current biology, 2002-06, Vol.12 (11), p.919-924

2002

Link zum Volltext

Verfügbarkeit prüfen

Identification and analysis of the active phytochemicals from the anti-cancer botanical extract Bezielle

PloS one, 2012-01, Vol.7 (1), p.e30107

2012

Link zum Volltext

Verfügbarkeit prüfen

Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS

PloS one, 2012-02, Vol.7 (2), p.e30300-e30300

2012

Link zum Volltext

Verfügbarkeit prüfen

Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress

PloS one, 2009-09, Vol.4 (9), p.e7283-e7283

2009

Link zum Volltext

Verfügbarkeit prüfen

A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma

Oncogene, , Vol.14 (18), p.2167-2173

SHTIVELMAN, E

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression

Proceedings of the National Academy of Sciences - PNAS, 2010-10, Vol.107 (43), p.18616-18621

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Nuclear Import by the Proapoptotic Protein CC3

Molecular and Cellular Biology, 2004-08, Vol.24 (16), p.7091-7101

2004

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells

Cancer biology & therapy, 2008-04, Vol.7 (4), p.577-586

2008

Link zum Volltext

Verfügbarkeit prüfen

Systemic Gene Delivery Expands the Repertoire of Effective Antiangiogenic Agents

The Journal of biological chemistry, 1999-05, Vol.274 (19), p.13338-13344

1999

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4255: Concurrent KRAS and TP53 mutations in pancreatic cancer real-world data (RWD) highlight convergent tumor evolutionary patterns

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4255-4255

2023

Link zum Volltext

Verfügbarkeit prüfen

Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR

Molecular cancer research, 2003-11, Vol.1 (13), p.959-969

Shtivelman, Emma

2003

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2

Breast cancer research and treatment, 2011-10, Vol.129 (3), p.777-784

2011

Link zum Volltext

Verfügbarkeit prüfen

Alternatively Spliced Products CC3 and TC3 Have Opposing Effects on Apoptosis

Molecular and Cellular Biology, 2000-01, Vol.20 (2), p.583-593

2000

Link zum Volltext

Verfügbarkeit prüfen

A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma

Oncogene, 1997-05, Vol.14 (18), p.2167-2173

Shtivelman, E

1997

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Chk1 by Activated PKB/Akt

Cell cycle (Georgetown, Tex.), 2004-05, Vol.3 (5), p.632-635

2004

Link zum Volltext

Verfügbarkeit prüfen

Bezielle (BZL101)‐induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study

International journal of cancer, 2011-12, Vol.129 (12), p.2945-2957

2011

Link zum Volltext

Verfügbarkeit prüfen

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

Cell, 1986-10, Vol.47 (2), p.277-284

1986

Link zum Volltext

Verfügbarkeit prüfen

phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer

Breast cancer research and treatment, 2010-02, Vol.120 (1), p.111-118

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase i trial and antitumor effects of BZL101 for patients with advanced breast cancer

Breast cancer research and treatment, 2007-09, Vol.105 (1), p.17-28

2007

Link zum Volltext

Verfügbarkeit prüfen

Promotion of Mitosis by Activated Protein Kinase B After DNA Damage Involves Polo-Like Kinase 1 and Checkpoint Protein CHFR11Institutional funds from the Cancer Research Institute, University of California San Francisco

Molecular cancer research, 2003-11, Vol.1 (13), p.959

Emma Shtivelman

2003

Link zum Volltext

Verfügbarkeit prüfen

Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid

International journal of cancer, 2010-09, Vol.127 (5), p.1209-1219

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)
Berichte
(1)

Sprache

Englisch
(50)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Humans
(34)
Life Sciences & Biomedicine
(27)
Biological And Medical Sciences
(17)
Animals
(16)
Cell Biology
(16)
Oncology
(14)
Tumors
(11)
Cell Line, Tumor
(10)
Proteins
(10)
Cancer
(9)
Female
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Apoptosis
(8)
Biochemistry & Molecular Biology
(8)
Breast Cancer
(8)
Cell Line
(8)
Medical Sciences
(8)
Molecular And Cellular Biology
(8)
Multidisciplinary Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathways and therapeutic targets in melanoma

Molecular pathways and therapeutic targets in lung cancer

Molecular pathways and targets in prostate cancer

CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation

A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle

Identification and analysis of the active phytochemicals from the anti-cancer botanical extract Bezielle

Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS

Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress

A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma

Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression

Inhibition of Nuclear Import by the Proapoptotic Protein CC3

Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells

Systemic Gene Delivery Expands the Repertoire of Effective Antiangiogenic Agents

Abstract 4255: Concurrent KRAS and TP53 mutations in pancreatic cancer real-world data (RWD) highlight convergent tumor evolutionary patterns

Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR

Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2

Alternatively Spliced Products CC3 and TC3 Have Opposing Effects on Apoptosis

A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma

Inhibition of Chk1 by Activated PKB/Akt

Bezielle (BZL101)‐induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer

Phase i trial and antitumor effects of BZL101 for patients with advanced breast cancer

Promotion of Mitosis by Activated Protein Kinase B After DNA Damage Involves Polo-Like Kinase 1 and Checkpoint Protein CHFR11Institutional funds from the Cancer Research Institute, University of California San Francisco

Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid

Suchergebnisse filtern